IIN AOI EFFICACY OF FIFLOW AQI AS A RESCUE FOR POLLUTED SKIN FIFLOW AQI (Perfluorohexane (and) Perfluoroperhydrophenanthrene (and) Perfluoro Dimethylethylpentane) is a completely inert liquid, which has the capacity to clean the skin from gas pollutants.
refid# nkYvyQ1Ze3wOk1dBEvQ4Qy4k82 pages
Application note | 001715 Environmental High-throughput analysis of both neutral and ionic PFAS in ambient air using thermal desorption coupled to gas chromatography - mass spectrometry (TD-GC-MS/MS) Authors Laura Miles,1 Hannah Calder,1 Vladimir Nikiforov,2 Dorte Herzke,2 Nicholas Warner,3 Giulia Riccardino,4 Adam Ladak,5 and Daniel Kutscher3 1Markes International Ltd, Bridgend, UK 2NILU-Norwegian Institute for Air Research, Fram Centre, Troms, Norway Thermo Fisher Scientific 3Bremen, DE; 4Milan, IT; 5Hemel Hempstead, UK Keywords Polyfluoroalkyl substances (PFAS), air monitoring, pollution, thermal desorption, TD 100-xr Advanced, gas chromatography-mass spectrometry, GC-MS, triple quadrupole, TSQ 9610, Advanced Ionization Ion source (AEI), TRACE 1610 GC Goal The aim of this application note is to demonstrate a high-throughput method for the simultaneous analysis of neutral (FTOH, FOSA) and ionic (PFCA, FTCA) per- and polyfluoroalkyl substances (PFAS) in air using thermal desorption coupled to gas chromatography mass spectrometry.
refid# dYDKyRqVk9Jp4k4BMv60mLBmB9 pages
refid# 71QvjKqRK4YBy1710bGGMY7ba2 pages
D - 44149 Dortmund, Germany phone: fax: e-mail: 2
refid# 2jvQD5EBE7mwvpqKryGm9nBZr2 pages
refid# e1nBrz4q8MdpGQpvxkVyZO80M1 page
refid# aBaRgoaJXyjvYqL57p8eZy6vN1 page
database MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary name MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary source-app Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero name2 Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero ref-type name3 27 Report 27 Report 27 Report 27 Report 27 Report 17 Journal Article 27 Report 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 5 Book Section 5 Book Section 5 Book Section 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 5 Book Section MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero 5 Book Section 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary MyLibrary Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero Zotero 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Article 17 Journal Arti
refid# xdekkGO8v7BKkOjkQV5jja2N6387 pages
dd Dec 20 WP WP0 DE/NL Responsible WP1 DE/NL Activities Coordination Preparation of Call for Evidence (including questionnaire and information document) in agreement between MS Call for Evidence (all MS and ECHA with news alerts and websites of all MS with Link to Helpdesk webpage) Preparation of Restriction option analysis document (all MS) RIME+ Dortmund 1st draft of restriction option analysis document (all MS) 2nd draft of restriction option analysis document (all MS) Finalisation of document, i.e. clarification of restriction options and scope (all MS) Restriction option analysis document to be uploaded on CIRCA (DE/ NL CA) RMOA-Conclusion, PACT-Update WP2 Drafting discussion paper NL Wordt vragenlijst + aanvulling 1e discussion paper WP3 DE/DK DE/DK WP4 NL/DE Verwerken commentaren van NO, SE, DE, I&W en RIVM deskundigen Coordination and alignment Pre-phase for environmental and human health hazard assessment --> Overview of relevant hazards (besides persistence) and generation of draft lists of substances for assessment Assessment phase --> Draft text for restriction proposal WP5 NO WP6 SE/DE Overview analytical methods (ch E7) Overview human and environmental monitoring data Working plan Design template for collection of monitoring date Presentation of slide WP6 at RiME Meeting wieh NCSU Collect monitoring data - ENV Collect monitoring data - HUM RiME FEB-2021 WP7 Scoping essential use NL Scoping impact assessment Baseline and restriction scenario(s) Economic impact assessment Environmental impact assessment Health impact assessment Assessment of other impacts Proportionality analysis Monthly meetings starts 2nd version questionnaire Draft of information document (DE/NL CA) Commenting round (all MS) Revision and draft of 3rd version of questionnaire and information document for WebEx (DE/NL CA) Detailed discussion of questionnaire and information document (all MS) Webex Final version (DE/ NL CA) Notification into PACT (DE/ NL CA) Discussion of responses received so far, data (all MS) Webex Decision on meetings with industry (all MS) DDiescciusisosnioonnowf rheiscthrircetisotrnicstcioonpeopantidonospstihoonusld(ablleMpSre) sWenetbeedx and discussed in RiME+ (all MS) Meetings with stakeholders and industry Presentation on RMOA for RiME May 2020 Contributions of first drafts of document parts according to lead in work packages and sub-work packages (all MS) Merge of contributions, redrafting (DE/ NL CA) Redrafting by all MS Merge of contributions, redrafting (DE/ NL CA) 31-Mar-20 4-May-20 August/September 2020 20/21 October 2020 25-Sep-20 5-Oct-20 19-Oct-20 Last redrafting by all MS Finalisation (DE/ NL CA) Commenting (by all other MS not part of group) Consideration of comments/if needed redrafting of document (DE/ NL CA in agreement with group) Webex meeting for initial discussing based on broad definition (NL, DE, SE, DK, NO, ECHA, COM) 1st discussion paper prepared by NL Face-to-face meeting (NL, DE, SE, DK, NO, ECHA, COM) based on discussion paper 2nd discussion paper prepared by NL (before RiME+) 26-Oct-20 10-Nov-20 23 - 27 November 2020 1-Dec-20 4-Jan-21 Discussion during RiME+ meeting Final discussion paper prepared by NL 2021 - TO BE PREPARED Kick-off meeting Joint HH/ENV progress meetings HH subgroup meetings ENV subgroup meetings Start up, Develop generic information basis for all sub-uses, structure of the sub-use reports (by WP7) - DONE Kick-off meeting (Discussion of content of each sub-use to avoid overlaps and discussion of revision of list of sub-uses and discussion of ETH Zrich work) - DONE 1 May 2020 1 Nov. 2020 Start up sub uses, Project plan fine tuning for sub-uses (and if needed tendering for consultants) Progress meeting after CfE is closed to check sub-uses, decide on stakeholder meetings (i.e. via mail) Stakeholder Meetings per sub-use: Follow up on information from CfE and to address knowledge gaps Sub-use studies (including gap analysis) Progress meeting Progress meeting Final reports consultants (& feedback to WP2) Integration of information (including gap analysis) Additional studies (i.e. membranes, processing aids?)
refid# emLmY7aOBppOm8VvjNXq6ayg440 pages
Fluoropolymer lined steel pipe External coating steel pipe Resin-lined steel pipes protect steel pipes from corrosion by forming a resin film on the inner surface of the base steel pipe.
refid# k65G95kRmROXKEMQZpn98428y2 pages
Montesiro Cookware srl non-stick coating divisjon Via Cimabue, 16 -- Fraz.
refid# wrv4Q4rodoMZmxyrqvzmXG0wE2 pages
Application for Derogations from PFAS REACH restriction for Permanent Exemption of Fluoropolymers and Proton Exchange Membranes for Fuel Cells Topic: Application for permanent exemption of fluoropolymers and proton exchange membranes for fuel cells Scope: Monomers, synthetic fluoropolymer resins, proton exchange membrane products, fuel cells ---- "" The fuel cell is a chemical battery that uses the energy released during a chemical reaction to convert it directly into electricity.
refid# OrX4JvbnXNxgkMBmN3N8vZ113 pages
Executive Summary.............................................................................................................................................................................. 1 1.0 Introduction ........................................................................................................................................................................... 2 2.0 Results ...................................................................................................................................................................................... 3 3.0 Process Description............................................................................................................................................................. 4 4.0 Stack Test Procedures and Methods............................................................................................................................ 5 Table ES-1 Table 4-1 Extruder Exhaust PFAS Test Results (3 Run Average) ...........................................................................1 EPA Method 1 Test Location Criteria ..........................................................................................................5 Table 1 PFAS Test Results -- Extruder Exhaust Figure 1 Figure 2 Test Port Locations-- Extruder Exhaust Traverse Point Locations-- Extruder Exhaust Appendix A Appendix B Appendix C Appendix D Appendix E Report Calculations and Nomenclature Field Data Sheets Laboratory Reports and Sample Chain of Custody Calibration Data Project Participants Barr Engineering Co.
refid# e7ZgzjGMOQ20rKJj99byrRBNp190 pages
I.V.STAR Filter Infusion filters and filter systems I.V.STAR Filter Safe and reliable: I.V.STAR Infusion filters from CODAN With the infusion filters and complete filter systems from the I.V.STAR series, CODAN sets standards in infusion therapy.
refid# rp847GymGknL545b0RNOOOGjv6 pages
8/25/23, 12:06 PM Maximum Continuous Service Temperature - Plastic Properties The material selection platform Plastics & Elastomers Max Continuous Service Temperature 1.
refid# 6RqnYQ9m5zL6nL5XNZy0do9dR9 pages
Remarks Scope defined for RoI (exclusion WP2 and possible E-use WP7) Scope defined for Annex XV report (ongoing assessments can still lead to changes in scope i.e. substances/substance groups to be excluded, uses to be derogated etc.)
refid# 5L9LRJDOBaDXkD2oDDXOY0ygD8 pages